Drug Discovery

Novosteo has developed a targeted drug combination to help accelerate the repair of bone fractures.

Novel compounds could be effective in treating brain-eating amoeba.

What is the current situation for rare diseases and orphan drug development?

How can advanced diagnostics be used to develop a new treatment for COVID-19?

Carlo Toniatti takes us on a journey from the clinic, to academia, to industry, and shares his lessons learned along the way.

How can the progression of Parkinson's disease be slowed?

Repurposing drugs could accelerate the development of a new cystic fibrosis drug.

Sitting down with… Matthew Todd, Chair of Drug Discovery at UCL and founder of the Open Source Pharma movement.

What challenges do manufacturers face in developing ADCs?

How is pharma using advances in technology to its benefit?